| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Hematology and Oncology, Children's Hospital, Ruprecht-Karls University, INF 150, 69120 Heidelberg, Germany [T. F., E. A., S. B., L. S.]; Institute of Histology and Embryology, Department of Morphology, University Medical Center 1121 Geneva 4, Switzerland [M. S. P., R. M.]; Department of Chemistry, Organic Chemistry Laboratory, P. O. Box 55, University of Helsink, FIN-00014 Helsinki, Finland [S. R., K. W.]; Department of Clinical Chemistry, Meilahti Hospital, University of Helsinki, SF-00290 Helsinki, Finland [H. A.]
Consumption of a plant-based diet can prevent the development and progression of chronic diseases associated with extensive neovascularization, including solid malignant tumors. In previous studies, we have shown that the plant-derived isoflavonoid genistein is a potent inhibitor of cell proliferation and in vitro angiogenesis. In the present study, we report that certain structurally related flavonoids are more potent inhibitors than genistein. Indeed, 3-hydroxyflavone, 3',4'-dihydroxyflavone, 2',3'-dihydroxyflavone, fisetin, apigenin, and luteolin inhibited the proliferation of normal and tumor cells, as well as in vitro angiogenesis, at half-maximal concentrations in the low micromolar range. We have previously demonstrated that genistein concentrations in the urine of subjects consuming a plant-based diet is 30-fold higher than in subjects consuming a traditional Western diet. The wider distribution and the more abundant presence of flavonoids in the plant kingdom, together with the present results, suggest that flavonoids may contribute to the preventive effect of a plant-based diet on chronic diseases, including solid tumors.
1 Work in Heidelberg was supported by grants from Deutsche Forschungsgemeinschaft, Kulemann-Stiftung. and Deutsche Krebshilfe; work in Geneva by Grant 31-43364.95 from the Swiss National Science Foundation; and work in Helsinki by grants from the Finnish Cancer Foundation and the Sigrid Juselius Foundation.
2 To whom requests for reprints should be addressed, at Laboratory of Biological Chemistry. Medical School, University of Ioannina, 45110 Ioannina, Greece. Phone: (30)651 28388; Fax: (30)651 33442; E-mail: thfotsis@cc.uoi.gr.
3 Present address: Department of Hematology, Oncology and Endocrinology, Children's Hospital. University of Essen, Hufelandstrasse 55, 45122 Essen, Germany.
Received 1/ 7/97. Accepted 5/13/97.
This article has been cited by other articles:
![]() |
A.-L. Salmela, J. Pouwels, A. Varis, A. M. Kukkonen, P. Toivonen, P. K. Halonen, M. Perala, O. Kallioniemi, G. J. Gorbsky, and M. J. Kallio Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint Carcinogenesis, June 1, 2009; 30(6): 1032 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Kang, K. W. Lee, J. Y. Kwon, M. K. Hwang, E. A. Rogozin, Y.-S. Heo, A. M. Bode, H. J. Lee, and Z. Dong Delphinidin Attenuates Neoplastic Transformation in JB6 Cl41 Mouse Epidermal Cells by Blocking Raf/Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Signaling Cancer Prevention Research, December 1, 2008; 1(7): 522 - 531. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lamy, V. Bedard, D. Labbe, H. Sartelet, C. Barthomeuf, D. Gingras, and R. Beliveau The Dietary Flavones Apigenin and Luteolin Impair Smooth Muscle Cell Migration and VEGF Expression through Inhibition of PDGFR-{beta} Phosphorylation Cancer Prevention Research, November 1, 2008; 1(6): 452 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Yang, W.-E. Yang, H.-R. Chang, S.-C. Chu, and Y.-S. Hsieh Luteolin Induces Apoptosis in Oral Squamous Cancer Cells Journal of Dental Research, April 1, 2008; 87(4): 401 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shukla, G. T. MacLennan, C. A. Flask, P. Fu, A. Mishra, M. I. Resnick, and S. Gupta Blockade of {beta}-Catenin Signaling by Plant Flavonoid Apigenin Suppresses Prostate Carcinogenesis in TRAMP Mice Cancer Res., July 15, 2007; 67(14): 6925 - 6935. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fang, Q. Zhou, L.-Z. Liu, C. Xia, X. Hu, X. Shi, and B.-H. Jiang Apigenin inhibits tumor angiogenesis through decreasing HIF-1{alpha} and VEGF expression Carcinogenesis, April 1, 2007; 28(4): 858 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fang, Q. Zhou, X.-l. Shi, and B.-h. Jiang Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells Carcinogenesis, March 1, 2007; 28(3): 713 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tong, R. T. Van Dross, A. Abu-Yousif, A. R. Morrison, and J. C. Pelling Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational Inhibition Mol. Cell. Biol., January 1, 2007; 27(1): 283 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fu, J. Xue, Z. Li, X. Shi, B.-H. Jiang, and J. Fang Chrysin inhibits expression of hypoxia-inducible factor-1{alpha} through reducing hypoxia-inducible factor-1{alpha} stability and inhibiting its protein synthesis Mol. Cancer Ther., January 1, 2007; 6(1): 220 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Balasubramanian, L. Zhu, and R. L. Eckert Apigenin Inhibition of Involucrin Gene Expression Is Associated with a Specific Reduction in Phosphorylation of Protein Kinase C{delta} Tyr311 J. Biol. Chem., November 24, 2006; 281(47): 36162 - 36172. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schindler and R. Mentlein Flavonoids and Vitamin E Reduce the Release of the Angiogenic Peptide Vascular Endothelial Growth Factor from Human Tumor Cells J. Nutr., June 1, 2006; 136(6): 1477 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Singh, A. A. Franke, G. L. Blackburn, and J.-R. Zhou Soy Phytochemicals Prevent Orthotopic Growth and Metastasis of Bladder Cancer in Mice by Alterations of Cancer Cell Proliferation and Apoptosis and Tumor Angiogenesis Cancer Res., February 1, 2006; 66(3): 1851 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Z. Liu, J. Fang, Q. Zhou, X. Hu, X. Shi, and B.-H. Jiang Apigenin Inhibits Expression of Vascular Endothelial Growth Factor and Angiogenesis in Human Lung Cancer Cells: Implication of Chemoprevention of Lung Cancer Mol. Pharmacol., September 1, 2005; 68(3): 635 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Davis-Searles, Y. Nakanishi, N.-C. Kim, T. N. Graf, N. H. Oberlies, M. C. Wani, M. E. Wall, R. Agarwal, and D. J. Kroll Milk Thistle and Prostate Cancer: Differential Effects of Pure Flavonolignans from Silybum marianum on Antiproliferative End Points in Human Prostate Carcinoma Cells Cancer Res., May 15, 2005; 65(10): 4448 - 4457. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fang, C. Xia, Z. Cao, J. Z. Zheng, E. Reed, and B.-H. Jiang Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways FASEB J, March 1, 2005; 19(3): 342 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Panopoulou, C. Murphy, H. Rasmussen, E. Bagli, E. K. Rofstad, and T. Fotsis Activin A Suppresses Neuroblastoma Xenograft Tumor Growth via Antimitotic and Antiangiogenic Mechanisms Cancer Res., March 1, 2005; 65(5): 1877 - 1886. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Torkin, J.-F. Lavoie, D. R. Kaplan, and H. Yeger Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma Mol. Cancer Ther., January 1, 2005; 4(1): 1 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bagli, M. Stefaniotou, L. Morbidelli, M. Ziche, K. Psillas, C. Murphy, and T. Fotsis Luteolin Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis; Inhibition of Endothelial Cell Survival and Proliferation by Targeting Phosphatidylinositol 3'-Kinase Activity Cancer Res., November 1, 2004; 64(21): 7936 - 7946. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Van Dross, Y. Xue, A. Knudson, and J. C. Pelling The Chemopreventive Bioflavonoid Apigenin Modulates Signal Transduction Pathways in Keratinocyte and Colon Carcinoma Cell Lines J. Nutr., November 1, 2003; 133(11): 3800S - 3804. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Matsuoka, K. Fukamachi, T. Hamaguchi, H. Toriyama-Baba, H. Kawaguchi, M. Kusunoki, H. Yoshida, and H. Tsuda Rapid Emergence of Mammary Preneoplastic and Malignant Lesions in Human c-Ha-ras Proto-Oncogene Transgenic Rats: Possible Application for Screening of Chemopreventive Agents Toxicol Pathol, October 1, 2003; 31(6): 632 - 637. [Abstract] [PDF] |
||||
![]() |
L. Favot, S. Martin, T. Keravis, R. Andriantsitohaina, and C. Lugnier Involvement of cyclin-dependent pathway in the inhibitory effect of delphinidin on angiogenesis Cardiovasc Res, August 1, 2003; 59(2): 479 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yu, G. L. Blackburn, and J.-R. Zhou Genistein and Daidzein Downregulate Prostate Androgen-Regulated Transcript-1 (PART-1) Gene Expression Induced by Dihydrotestosterone in Human Prostate LNCaP Cancer Cells J. Nutr., February 1, 2003; 133(2): 389 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Weiger, M. Smith, H. Boon, M. A. Richardson, T. J. Kaptchuk, and D. M. Eisenberg Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer Ann Intern Med, December 3, 2002; 137(11): 889 - 903. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Frigo, B. N. Duong, L. I. Melnik, L. S. Schief, B. M. Collins-Burow, D. K. Pace, J. A. McLachlan, and M. E. Burow Flavonoid Phytochemicals Regulate Activator Protein-1 Signal Transduction Pathways in Endometrial and Kidney Stable Cell Lines J. Nutr., July 1, 2002; 132(7): 1848 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. KOTANIDOU, A. XAGORARI, E. BAGLI, P. KITSANTA, T. FOTSIS, A. PAPAPETROPOULOS, and C. ROUSSOS Luteolin Reduces Lipopolysaccharide-induced Lethal Toxicity and Expression of Proinflammatory Molecules in Mice Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 818 - 823. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Singh, A. K. Tyagi, J. Zhao, and R. Agarwal Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis Carcinogenesis, March 1, 2002; 23(3): 499 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Alhasan, O. Aranha, and F. H. Sarkar Genistein Elicits Pleiotropic Molecular Effects on Head and Neck Cancer Cells Clin. Cancer Res., December 1, 2001; 7(12): 4174 - 4181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J Nijveldt, E. van Nood, D. E. van Hoorn, P. G Boelens, K. van Norren, and P. A. van Leeuwen Flavonoids: a review of probable mechanisms of action and potential applications Am. J. Clinical Nutrition, October 1, 2001; 74(4): 418 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Xagorari, A. Papapetropoulos, A. Mauromatis, M. Economou, T. Fotsis, and C. Roussos Luteolin Inhibits an Endotoxin-Stimulated Phosphorylation Cascade and Proinflammatory Cytokine Production in Macrophages J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 181 - 187. [Abstract] [Full Text] |
||||
![]() |
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Lin, B.-K. Moon, F. Yu, and H.-R. C. Kim Galectin-3 mediates genistein-induced G2/M arrest and inhibits apoptosis Carcinogenesis, November 1, 2000; 21(11): 1941 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Walgren, K. J. Karnaky Jr., G. E. Lindenmayer, and T. Walle Efflux of Dietary Flavonoid Quercetin 4'-beta -Glucoside across Human Intestinal Caco-2 Cell Monolayers by Apical Multidrug Resistance-Associated Protein-2 J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 830 - 836. [Abstract] [Full Text] |
||||
![]() |
S. Breit, K. Ashman, J. Wilting, J. Rössler, E. Hatzi, T. Fotsis, and L. Schweigerer The N-myc Oncogene in Human Neuroblastoma Cells: Down-Regulation of an Angiogenesis Inhibitor Identified as Activin A Cancer Res., August 1, 2000; 60(16): 4596 - 4601. [Abstract] [Full Text] |
||||
![]() |
M. McVean, H. Xiao, K.-i. Isobe, and J. C. Pelling Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes Carcinogenesis, April 1, 2000; 21(4): 633 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Reiners Jr, R. Clift, and P. Mathieu Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor Carcinogenesis, August 1, 1999; 20(8): 1561 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ji, G. M. Willis, G. R. Frank, S. G. Cornelius, and M. E. Spurlock Soybean Isoflavones, Genistein and Genistin, Inhibit Rat Myoblast Proliferation, Fusion and Myotube Protein Synthesis J. Nutr., July 1, 1999; 129(7): 1291 - 1297. [Abstract] [Full Text] |
||||
![]() |
G. G. J. M. Kuiper, J. G. Lemmen, B. Carlsson, J. C. Corton, S. H. Safe, P. T. van der Saag, B. van der Burg, and J.-A. Gustafsson Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor {beta} Endocrinology, October 1, 1998; 139(10): 4252 - 4263. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |